Page 10
Mimura T, Relationship between HLA and retinopathy in patients with type 1 diabetes
REFERENCES
1. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin
Epidemiologic Study of Diabetec Retinopathy. II. Prevalence and risk of diabetic
retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol
1984;102;520-526.
2. Funatsu H, Hori S, Ohashi Y, Ishigaki T. Risk factors for occurrence and
progression of diabetic retinopathy. Nippon Ganka Gakkai Zasshi
1993;97;939-946.
3. Sakane N, Yoshida T, Yoshida K, et al. Beta 3-adrenoreceptor gene polymorphism:
a newly identified risk factor for proliferative retinopathy in NIDDM patients.
Diabetes 1997;6;1633-1636.
4. Vendrell J, Gutierrez C, Broch M, Fernandez-Real JM, Aguilar C, Richart C. Beta
3-adrenoreceptor gene polymorphism and leptin. Lack of relationship in type 2
diabetic patients. Clin Endocrinol (Oxf) 1988;49;679-683.
5. Tarnow L, Urhammer SA, Mottlau B, Hansen BV, Pedersen O, Parving HH. The
Trp66Arg amino acid polymorphism of the beta3-adrenergic receptor gene does not
contribute to the genetic susceptibility of diabetic microvascular complications in
Caucasian type 1 diabetic patients. Nephrol Dial Transplant 1999;14;895-897.
